OLD Point Trust & Financial Services N A Reduces Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

OLD Point Trust & Financial Services N A lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 20.1% during the 4th quarter, HoldingsChannel reports. The fund owned 8,091 shares of the pharmacy operator’s stock after selling 2,030 shares during the period. OLD Point Trust & Financial Services N A’s holdings in Walgreens Boots Alliance were worth $75,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in WBA. State Street Corp grew its position in Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after acquiring an additional 6,569,223 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Walgreens Boots Alliance by 19.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock worth $122,737,000 after purchasing an additional 2,185,950 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Walgreens Boots Alliance by 12.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after buying an additional 817,762 shares during the period. Thompson Siegel & Walmsley LLC lifted its holdings in Walgreens Boots Alliance by 15.5% during the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock valued at $62,325,000 after buying an additional 934,754 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in Walgreens Boots Alliance by 9.6% in the 4th quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator’s stock valued at $50,684,000 after buying an additional 478,061 shares during the period. Institutional investors own 58.59% of the company’s stock.

Analysts Set New Price Targets

WBA has been the topic of a number of research reports. Evercore ISI raised their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. StockNews.com initiated coverage on Walgreens Boots Alliance in a research report on Tuesday. They set a “hold” rating for the company. Truist Financial dropped their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Finally, Bank of America increased their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $10.59.

Walgreens Boots Alliance Price Performance

NASDAQ WBA opened at $11.16 on Thursday. The firm’s fifty day simple moving average is $10.93 and its two-hundred day simple moving average is $9.80. The firm has a market capitalization of $9.64 billion, a P/E ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the previous year, the business earned $0.66 EPS. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. Analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.